Indian Journal of Microbiology

, Volume 57, Issue 3, pp 307–315 | Cite as

Targeted Metagenome Based Analyses Show Gut Microbial Diversity of Inflammatory Bowel Disease patients

  • Zhibing Qiu
  • Haijing Yang
  • Lan Rong
  • Weiqun Ding
  • Jiazhen Chen
  • Liang ZhongEmail author
Original Article


Inflammatory bowel disease (IBD) is a multifactorial disease including both genetic and environmental factors. We compared the diversity of intestinal microbesamong a cohort of IBD patients to study the microbial ecological effects on IBD. Fecal samples from patients were sequenced with next generation sequence technology at 16S rDNA region. With statistical tools, microbial community was investigated at different level. The gut microbial diversity of Crohn’s disease (CD) patients and colonic polyp (CP) patients significantly different from each other. However, the character of ulcerative colitis (UC) patients has of both CD and CP features. The microbial community from IBD patients can be very different (CD patient) or somewhat similar (UC patients) to non-IBD patients. Microbial diversity can be an important etiological factor for IBD clinical phenotype.


Microbial diversity 16S rDNA Inflammatory bowel disease (IBD) Statistical analysis 



This work was supported by Grants from the Shanghai Municipal Commission of Health and Family Planning (No. 20124011), the Shanghai Municipal Commission of Health and Family Planning (No. 20164Y0153).

Supplementary material

12088_2017_652_MOESM1_ESM.rar (73 kb)
Supplementary material 1 (RAR 73 kb)


  1. 1.
    Bouma G, Strober W (2003) The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3:521–533. doi: 10.1038/nri1132 CrossRefPubMedGoogle Scholar
  2. 2.
    Harlan WR, Meyer A, Fisher J (2016) Inflammatory bowel disease: epidemiology, evaluation, treatment, and health maintenance. N C Med J 77:198–201. doi: 10.18043/ncm.77.3.198 PubMedGoogle Scholar
  3. 3.
    Burisch J, Munkholm P (2015) The epidemiology of inflammatory bowel disease. Scand J Gastroenterol 50:942–951. doi: 10.3109/00365521.2015.1014407 CrossRefPubMedGoogle Scholar
  4. 4.
    Xiao B, Merlin D (2012) Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease. Expert Opin Drug Deliv 9:1393–1407. doi: 10.1517/17425247.2012.730517 CrossRefPubMedGoogle Scholar
  5. 5.
    Halme L, Paavola-Sakki P, Turunen U, Lappalainen M, Farkkila M, Kontula K (2006) Family and twin studies in inflammatory bowel disease. World J Gastroenterol 12:3668–3672. doi: 10.3748/wjg.v12.i23.3668 CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Van Limbergen J, Russell RK, Nimmo ER, Satsangi J (2007) The genetics of inflammatory bowel disease. Am J Gastroenterol 102:2820–2831. doi: 10.1111/j.1572-0241.2007.01527.x CrossRefPubMedGoogle Scholar
  7. 7.
    Cho JH, Weaver CT (2007) The genetics of inflammatory bowel disease. Gastroenterology 133:1327–1339. doi: 10.1053/j.gastro.2007.08.032 CrossRefPubMedGoogle Scholar
  8. 8.
    Hampe J, Franke A, Rosenstiel P, Till A, Teuber M, Huse K, Albrecht M, Mayr G, De La Vega FM, Briggs J et al (2007) A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 39:207–211. doi: 10.1038/ng1954 CrossRefPubMedGoogle Scholar
  9. 9.
    Parkes M, Barrett JC, Prescott NJ, Tremelling M, Anderson CA, Fisher SA, Roberts RG, Nimmo ER, Cummings FR, Soars D et al (2007) Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn’s disease susceptibility. Nat Genet 39:830–832. doi: 10.1038/ng2061 CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Rioux JD, Xavier RJ, Taylor KD, Silverberg MS, Goyette P, Huett A, Green T, Kuballa P, Barmada MM, Datta LW et al (2007) Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 39:596–604. doi: 10.1038/ng2032 CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    McCarroll SA, Huett A, Kuballa P, Chilewski SD, Landry A, Goyette P, Zody MC, Hall JL, Brant SR, Cho JH et al (2008) Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn’s disease. Nat Genet 40:1107–1112. doi: 10.1038/ng.215 CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Wellcome Trust Case Control C (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447:661–678. doi: 10.1038/nature05911 CrossRefGoogle Scholar
  13. 13.
    Franke A, Balschun T, Karlsen TH, Sventoraityte J, Nikolaus S, Mayr G, Domingues FS, Albrecht M, Nothnagel M, Ellinghaus D et al (2008) Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet 40:1319–1323. doi: 10.1038/ng.221 CrossRefPubMedGoogle Scholar
  14. 14.
    Silverberg MS, Cho JH, Rioux JD, McGovern DP, Wu J, Annese V, Achkar JP, Goyette P, Scott R, Xu W et al (2009) Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet 41:216–220. doi: 10.1038/ng.275 CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Fernando MM, Stevens CR, Walsh EC, De Jager PL, Goyette P, Plenge RM, Vyse TJ, Rioux JD (2008) Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet 4:e1000024. doi: 10.1371/journal.pgen.1000024 CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Round JL, Mazmanian SK (2009) The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9:313–323. doi: 10.1038/nri2515 CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Sartor RB (2008) Microbial influences in inflammatory bowel diseases. Gastroenterology 134:577–594. doi: 10.1053/j.gastro.2007.11.059 CrossRefPubMedGoogle Scholar
  18. 18.
    Donaldson GP, Lee SM, Mazmanian SK (2016) Gut biogeography of the bacterial microbiota. Nat Rev Microbiol 14:20–32. doi: 10.1038/nrmicro3552 CrossRefPubMedGoogle Scholar
  19. 19.
    Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, Gordon JI, Relman DA, Fraser-Liggett CM, Nelson KE (2006) Metagenomic analysis of the human distal gut microbiome. Science 312:1355–1359. doi: 10.1126/science.1124234 CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP et al (2009) A core gut microbiome in obese and lean twins. Nature 457:480–484. doi: 10.1038/nature07540 CrossRefPubMedGoogle Scholar
  21. 21.
    Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI (2005) Host-bacterial mutualism in the human intestine. Science 307:1915–1920. doi: 10.1126/science.1104816 CrossRefPubMedGoogle Scholar
  22. 22.
    Yadav V, Varum F, Bravo R, Furrer E, Bojic D, Basit AW (2016) Inflammatory bowel disease: exploring gut pathophysiology for novel therapeutic targets. Transl Res 176:38–68. doi: 10.1016/j.trsl.2016.04.009 CrossRefPubMedGoogle Scholar
  23. 23.
    Human Microbiome Project C (2012) A framework for human microbiome research. Nature 486:215–221. doi: 10.1038/nature11209 CrossRefGoogle Scholar
  24. 24.
    Human Microbiome Project C (2012) Structure, function and diversity of the healthy human microbiome. Nature 486:207–214. doi: 10.1038/nature11234 CrossRefGoogle Scholar
  25. 25.
    Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA (2005) Diversity of the human intestinal microbial flora. Science 308:1635–1638. doi: 10.1126/science.1110591 CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 104:13780–13785. doi: 10.1073/pnas.0706625104 CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Eckburg PB, Relman DA (2007) The role of microbes in Crohn’s disease. Clin Infect Dis 44(2):256–262. doi: 10.1086/510385 CrossRefPubMedGoogle Scholar
  28. 28.
    Xenoulis PG, Palculict B, Allenspach K, Steiner JM, Van House AM, Suchodolski JS (2008) Molecular-phylogenetic characterization of microbial communities imbalances in the small intestine of dogs with inflammatory bowel disease. FEMS Microbiol Ecol 66:579–589. doi: 10.1111/j.1574-6941.2008.00556.x CrossRefPubMedGoogle Scholar
  29. 29.
    Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humaran LG, Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G et al (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 105:16731–16736. doi: 10.1073/pnas.0804812105 CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Clemente JC, Ursell LK, Parfrey LW, Knight R (2012) The impact of the gut microbiota on human health: an integrative view. Cell 148:1258–1270. doi: 10.1016/j.cell.2012.01.035 CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Spor A, Koren O, Ley R (2011) Unravelling the effects of the environment and host genotype on the gut microbiome. Nat Rev Microbiol 9:279–290. doi: 10.1038/nrmicro2540 CrossRefPubMedGoogle Scholar
  32. 32.
    Perry S, de la Luz Sanchez M, Yang S, Haggerty TD, Hurst P, Perez-Perez G, Parsonnet J (2006) Gastroenteritis and transmission of Helicobacter pylori infection in households. Emerg Infect Dis 12:1701–1708. doi: 10.3201/eid1211.060086 CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Dicksved J, Halfvarson J, Rosenquist M, Jarnerot G, Tysk C, Apajalahti J, Engstrand L, Jansson JK (2008) Molecular analysis of the gut microbiota of identical twins with Crohn’s disease. ISME J 2:716–727. doi: 10.1038/ismej.2008.37 CrossRefPubMedGoogle Scholar

Copyright information

© Association of Microbiologists of India 2017

Authors and Affiliations

  1. 1.Department of Digestive Diseases, Huashan HospitalFudan UniversityShanghaiChina
  2. 2.Department of Infectious Diseases, Huashan HospitalFudan UniversityShanghaiChina

Personalised recommendations